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transmission is thought to play an important role in the pathophysiology of chronic tic disorders, such as
Tourette syndrome (TS). Therefore, the urinary concentrations of these TIQ derivatives were measured
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compared with controls. Seventeen patients with TS, 12 with TS and ADHD, and 19 age-matched
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Abstract
Tetrahydroisoquinolines (TIQs) such as salsolinol (SAL), norsalsolinol (NSAL) and their methylated derivatives N-methyl-
norsalsolinol (NMNSAL) and N-methyl-salsolinol (NMSAL), modulate dopaminergic neurotransmission and metabolism in 
the central nervous system. Dopaminergic neurotransmission is thought to play an important role in the pathophysiology of 
chronic tic disorders, such as Tourette syndrome (TS). Therefore, the urinary concentrations of these TIQ derivatives were 
measured in patients with TS and patients with comorbid attention-deficit/hyperactivity disorder (TS + ADHD) compared 
with controls. Seventeen patients with TS, 12 with TS and ADHD, and 19 age-matched healthy controls with no medica-
tion took part in this study. Free levels of NSAL, NMNSAL, SAL, and NMSAL in urine were measured by a two-phase 
chromatographic approach. Furthermore, individual TIQ concentrations in TS patients were used in receiver-operating 
characteristics (ROC) curve analysis to examine the diagnostic value. NSAL concentrations were elevated significantly 
in TS [434.67 ± 55.4 nmol/l (standard error of mean = S.E.M.), two-way ANOVA, p < 0.0001] and TS + ADHD patients 
[605.18 ± 170.21 nmol/l (S.E.M.), two-way ANOVA, p < 0.0001] compared with controls [107.02 ± 33.18 nmol/l (S.E.M.), 
two-way ANOVA, p < 0.0001] and NSAL levels in TS + ADHD patients were elevated significantly in comparison with TS 
patients (two-way ANOVA, p = 0.017). NSAL demonstrated an AUC of 0.93 ± 0.046 (S.E.M) the highest diagnostic value 
of all metabolites for the diagnosis of TS. Our results suggest a dopaminergic hyperactivity underlying the pathophysiology 
of TS and ADHD. In addition, NSAL concentrations in urine may be a potential diagnostic biomarker of TS.
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Introduction
Tics are short, non-rhythmic and non-purposeful single or 
short series of movements or vocalizations. Suppression 
can be achieved for a short time but the build-up of so-
called “premonitory urges” finally enforce the execution of 
a tic to release the pressure (Leckman et al. 1993). Tran-
sient tics occur during childhood and adolescence in up to 
15% of all healthy children (Robertson 2008). Persistence 
of tics for more than one year defines a chronic tic disor-
der, and the combination of chronic vocal and motoric tics 
is termed Tourette syndrome (TS) (American Psychiatric 
Association 2013). TS is typically associated with comor-
bid psychiatric conditions such as attention-deficit/hyper-
activity disorder (ADHD), obsessive compulsive disorder, 
anxiety and depression.
The etiology and pathophysiology underlying TS are 
still largely unknown. However, there is some evidence for 
a dopaminergic hyperinnervation in TS causing increased 
tonic and phasic dopaminergic neurotransmission in the 
basal ganglia (Maia and Conceição 2018). The efficacy of 
dopamine antagonists in the treatment of TS (Pringsheim 
et al. 2019) and exacerbation of tics by dopaminergic drugs 
like dextroamphetamine (Erenberg et al. 1985; Cohen et al. 
2015) underscore the relevance of this neurotransmitter 
system in this condition.
The dopamine-derived tetrahydroisoquinolines (TIQs) 
(R)-salsolinol (SAL) and norsalsolinol (NSAL) are syn-
thesized in the human brain from dopamine either by a 
non-enzymatic Pictet-Spengler reaction or enzymatically 
via salsolinol synthase (Fig. 1) (Moser 1998b). SAL and 
NSAL are metabolized by N-methyl-transferase into their 
N-methyl-derivatives N-methyl-salsolinol (NMSAL) 
and -norsalsolinol (NMNSAL) (Fig. 1) (Moser 1998b). 
There is evidence that these derivatives are involved in 
central dopamine metabolism (Briggs et al. 2013) and 
in the modulation of dopaminergic neurotransmission 
(Xie et al. 2012). In a previous study, we found higher 
concentrations of all these dopamine-derived metabolites 
in urine of ADHD patients, a condition also discussed to 
be associated with a disturbed dopamine neurotransmis-
sion (Roessner et al. 2007).
The aim of this study is to measure for the first time the 
concentrations of TIQs in the urine of patients with TS and 
patients with comorbid ADHD compared with controls. In 
addition, we want to explore the value of TIQs regarding 
the diagnosis of TS.
Methods
Subjects
The local ethics committee of the participating universities 
approved the study protocol. Seventeen children, adoles-
cents and young adults fulfilling the diagnostic criteria 
of chronic tic disorders (F95.1) including TS (F95.2) as 
referred to by the international classification of diseases 
in its 10th edition (ICD-10) (World Health Organization 
and Staff 1992) and 12 patients with this condition and a 
comorbid ADHD were included in this study. All patients 
were screened and diagnosed by a board-certified child and 
adolescent psychiatrist through a semi-structured inter-
view supported by diagnostic checklists. The characteris-
tics of the study cohort are shown in Table 1.
Patients were recruited in two sites (Departments of 
Child and Adolescent Psychiatry of the University Hospi-
tals of Wuerzburg and Goettingen). The patients and their 
parents or legal guardians gave informed consent.
The control group was recruited from 19 healthy chil-
dren and adolescents without any medication (either rela-
tives of hospital employees or from a school class in Goet-
tingen). A child and adolescent psychiatrist evaluated all 
participants in the control group to rule out the presence 
of psychiatric disorders.



































Altered urinary tetrahydroisoquinoline derivatives in patients with Tourette syndrome:…
1 3
Urine collection and analysis
Due to the presence of high levels of TIQ derivatives in 
certain types of food and beverages, participants were 
instructed to omit fresh and dried banana, cheese, choco-
late soy sauce, beer, port and white wine for 48 h before 
and during the sample collection. Psychostimulants were 
discontinued 48 h before the urine collection and reiniti-
ated after the collection. Intake of the other medication was 
continued during the study. Urine was collected starting at 
7 pm over 12 h in the presence of 50 mg semicarbazide and 
50 mg  Na2EDTA. After collection, samples were aliquoted 
and stored at − 40 °C until further analysis.
Samples were analyzed three times for all conditions by 
blinded staff. Analysis consisted of a two-stage process: (1) 
processing by affinity chromatography, (2) quantification of 
TIQ derivatives by high-performance liquid chromatography 
with electrochemical detection (HPLC/ECD) as previously 
described (Moser et al. 1996a). A rigorous quality control 
routine was employed by adding negative controls (water 
and urine of healthy persons with no measurable TIQ excre-
tion) and positive controls (water and urine of healthy per-
sons with all 4 TIQ added at 1 nmol/ml).
As described earlier (Moser 1998b), dihydroxylated TIQ 
derivatives are in part bound to sulfo- or gluco-residues. 
Bound metabolites can only be measured after deconjuga-
tion by incubation with arylsulfatases and β-glucuronidases. 
For this study, only free unconjugated metabolites were 
measured because conjugated metabolites are not able to 
modulate dopaminergic neurotransmission (Moser 1998b). 
SAL and NSAL are present in two enantiomeric forms ((S)-
SAL and N-(S)-SAL as well as (R)-SAL and N-(R)-SAL 
(Moser 1998a)). The analytic process did not differentiate 
between the two forms.
Statistics
Statistical analysis was performed with the GraphPad Prism 
8.02 software (GraphPad Software, San Diego, USA).
Data were expressed as mean values ± standard error of 
mean (S.E.M.). In order to rule out statistically significant 
differences in the mean age of the groups, an ordinary one-
way ANOVA with Tukey’s multiple comparisons test was 
performed. Differences in free urinary TIQ levels were ana-
lyzed by two-sided analyses of variance (two-way ANOVA) 
followed by the Sidak’s multiple comparison test. In order to 
determine the diagnostic value of individual TIQs for TS, the 
receiver-operating characteristics (ROC) curves including 
areas under the curve (AUC) were calculated for free urinary 
levels between the control and TS group.
Results
All mean values of free urinary TIQ levels were higher 
in patients with TS and comorbid ADHD than in con-
trols (Fig. 2). However, statistically significant differences 
were observed only for NSAL between TS and controls 
(p < 0.0001), TS + ADHD and controls (p < 0.0001) as well 
as TS and TS + ADHD (p = 0.017).
To determine the diagnostic qualities of TIQ values in 
respect of a diagnosis of TS, ROC curves including AUC 
were used. NSAL (0.93) and NMSAL (0.91) demonstrated 
higher AUC values than SAL (0.71) and NMNSAL (0.67). 
P values reached significance for NSAL (p < 0.0001), SAL 
(p = 0.04) and NMSAL (p < 0.0001).
Table 1  Demographic characteristics and psychopharmacological 
prescription of patients and controls taking part in the study
Controls TS TS + ADHD
Demographics
Subjects included 19 17 12
Subjects per site
Goettingen 8 13 6
Wuerzburg 11 4 6
M/F 10/9 13/4 11/1
Mean age ± S.E.M. 11.21 ± 1.1 y 13.04 ± 0.83 y 13 ± 0.95 y
Age range 5–20 y 6–22 y 7–19 y
Medication
Biperiden 0/19 0/17 2/12
Risperidone 0/19 17/17 2/12
Stimulants 0/19 0/17 10/12


































Fig. 2  Urinary levels of free tetrahydroisoquinoline derivatives in 
patients with chronic tic disorders including Tourette syndrome 
(TS), TS with comorbid attention-deficit/hyperactivity disorder 
(TS + ADHD) and age-matched healthy controls. (n = 17 for TS, 
n = 12 for TS + ADHD and n = 19 for controls, error bars represent 
standard error of the mean, two-way ANOVA with Sidak’s multiple 
comparison test, logarithmic scale). Please note: NMNSAL could not 
be detected in any control subject, therefore no corresponding bar is 
present in the graph
 P. Capetian et al.
1 3
Discussion
We found higher urinary concentrations of NSAL in TS 
patients compared with controls. Interestingly, the highest 
levels were measured in patients with TS and comorbid 
ADHD. A similar trend was observed for SAL (Fig. 1). 
These findings support the notion of a “hyperdopaminer-
gic” state in TS (Maia and Conceição 2018).
ADHD has already been described before as a condi-
tion associated with elevated TIQ levels (Roessner et al. 
2007). This assumption is strengthened by the fact that 
the original publication on elevated TIQ levels in ADHD 
patients (which recruited its patients in the same cent-
ers) exhibited the most pronounced elevation for NSAL 
as well. Furthermore, the mean NSAL level of ADHD 
patients in the mentioned study was 553.3 nmol/l and thus 
between the mean levels of TS patients (434.67 nmol/l) 
and TS + ADHD patients (605.18 nmol/l) in the present 
study. It seems consequential that patients suffering from 
two conditions associated with a potential hyperdopamin-
ergic state to have even higher TIQ levels than patients 
with only one of those.
TIQs are metabolized either directly from dopamine 
(NSAL and SAL) or from each other (NMNSAL from 
NSAL and NMSAL from SAL). TIQ levels were expressed 
as nmol/ml, a unit which showed the best correlation with 
derivates of the dopamine metabolism (homovanilic acid 
(HVA) and MDOPA) in the cerebrospinal fluid (CSF) of 
humans (Moser et al. 1996b).
Individual metabolites exhibit big differences between 
measured levels in the range of up to several 100 × and 
the differences are not necessarily consistent: NSAL lev-
els in our study are higher than NMNSAL levels that are 
metabolized from them. However, NMSAL derived from 
SAL exhibits higher levels. We hypothesize that different 
affinities of NSAL and SAL to the metabolizing enzymes 
(none of which have been characterized in detail for TIQs 
to our knowledge) could be the reason. On the other hand, 
the differences between controls and TS or TS + ADHD 
for all individual metabolites are constantly in a magni-
tude between fourfold and sevenfold. This fact increases 
in our opinion the likelihood of altered metabolite levels 
between controls, TS and TS + ADHD as consequence of 
differences in catecholamine levels. As TIQ derivatives 
can cross the blood–brain barrier, urinary levels can be 
expected to correlate with the levels in the brain and it 
has been demonstrated that they correlate with dopamine 
metabolites in the CSF (Moser et al. 1996b).
Our study demonstrated that TIQ metabolites might 
even carry a diagnostic value for TS. The metabolite with 
the biggest difference between TS and controls (NSAL) 
demonstrated a particularly high AUC. The diagnosis of 
tics and TS relies solely on clinical observation. The only 
study so far on the validity of TS diagnoses compared the 
prima vista diagnosis made by two movement disorder 
experts with the clinical diagnosis made by a much more 
comprehensive process in clinical routine in a tertiary 
center. It demonstrated a correct diagnosis in 71% and 
96% of cases based on a 20 s video of the individual tics 
with an inter-rater reliability of 0.71 (Paszek et al. 2010). 
Thus, clinical diagnosis is not flawless. However, if future 
studies might correlate TIQ levels to the severity and/or 
frequency of the occurrence of tics, they could become a 
valuable follow-up parameter for therapies and potentially 
select patients who might benefit from an anti-dopaminer-
gic therapy (Fig. 3).
A major potential confounder represents the ongoing 
medication of the patients. Due to their short half-life, 
psychostimulants were discontinued 48 h before the urine 
collection. Intake of the antipsychotic drugs (risperidone, 
tiapride) used to treat TS was not discontinued because 
of the longer time it would have taken for washout and 
reinitiating. Although it was shown in a positron emission 
tomography study in healthy subjects that oral administra-
tion of a single dose does not change the dopamine syn-
thesis capacity (Ito et al. 2009), it cannot be ruled out that 
chronic antipsychotic treatment affects central dopamine 
levels. In addition to the blockade of postsynaptic dopa-
mine D2 receptors, antipsychotics modulate presynaptic 
function. For example, increased dopamine release and 
increased dopamine metabolism have been reported fol-
lowing antipsychotic treatment in animal studies (Park 
et al. 2019).
Psychiatric comorbidity represents another potential 
confounder. ADHD is the most common comorbid con-
dition in TS (El Malhany et al. 2015) and was therefore 
included as an individual patient group in this study. We 
cannot fully rule out that the other comorbidities present in 
roughly 16% of TS and 25% of TS + ADHD patients in this 
study are associated with altered TIQ levels themselves 
and might alter TIQ levels.
As already mentioned, TIQs measured in the patient’s 
urine might as well come from alimentary sources. We 
therefore instructed patients to follow dietary restrictions 
on certain types of food and beverages and thus minimiz-
ing this confounder in our study. However, there was no 
possibility to objectify the adherence of individuals par-
taking in this study.
TIQ levels were measured in urine from a 12 h collec-
tion. This serves as a measure to compensate for potential 
diurnal changes in metabolite levels and their excretion. 
The completeness of the collection is fully dependent on 
the compliance of individuals in the study.
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Conclusions
We found elevated levels of NSAL in the urine of TS 
patients with and without comorbid ADHD in comparison 
with age-matched healthy children and adolescents. These 
results suggest higher dopamine synthesis in TS but have 
to be confirmed in studies with drug-naïve TS patients. 
NSAL as the metabolite with the biggest increase com-
pared with controls might also carry a diagnostic value for 
identifying patients with TS.
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